Key Points
-
Highlights that imaging is crucial in the staging of oral cancer.
-
Highlights that accurate staging is required so that appropriate treatment can be planned.
-
Suggests the common imaging modalities used to stage disease are computed tomography (CT), magnetic resonance imaging (MRI), ultrasound and positron emission tomography-computed tomography (PET-CT).
Abstract
The staging of oral cavity tumours as with all other malignancy subsites is undergoing a revision in the line with the updated American Joint Committee on Cancer guidelines. Of note, the new guidelines incorporate more emphasis on clinical and histopathological data. The aim of the new guidelines is to increase prognostic concordance between stage and survival. This article aims to review the multimodality approach to imaging of oral cavity malignancy. In addition, it will also review the multidisciplinary approach to diagnosis and management of these tumours as multiple specialities are crucial for effective treatment.
Introduction
Malignancy of the oral cavity, similarly to many other head and neck malignancy subsites, is increasing in prevalence.1
The oral cavity is lined by stratified squamous epithelium and is easily inspected clinically.2 Precise identification of the site of the primary cancer is essential. The anterior border of the oral cavity is the lips. The mylohyoid muscle separates the floor of the mouth and oral cavity from the suprahyoid neck (Fig. 1a). The roof is formed by the hard palate and posterior to it is the oropharyngeal soft palate. At the lateral aspect of the oral cavity is the buccal mucosa and the buccinator muscles. The oral tongue (anterior two thirds of the tongue) sits in the middle of the oral cavity and its junction with the posterior third of the tongue (oropharyngeal tongue) forms the posterior border of the oral cavity (Fig. 1b). The gingival mucosa carpets the maxillary and mandibular alveolar bone and surrounds the teeth. The triangular shaped areas of mucosa posterior to the last mandibular molar teeth are the retromolar trigones.
Most cancers of the oral cavity are squamous cell carcinomas (SCC). Though any oral cavity subsites can be involved, the site most commonly involved by SCC is the oral tongue.3 Separating the oral tongue from the oropharyngeal tongue (tongue base) is crucial in staging a P16 positive oropharyngeal primary carcinoma. The main aetiology factors for oral cancer are smoking and alcohol. HPV infection seems to be less important as an aetiological factor in oral cancer in comparison to oropharyngeal cancer.4 Diagnosis is usually made clinically and with biopsy for histological analysis.
Although the oral cavity and neck can be easily examined by dentists patients often present with advanced disease. Most patients will see their doctor rather than their dentist if they have an oral problem that is not tooth related.5
This article aims to review the multimodality approach to imaging of oral cavity malignancy. In addition, it will also review the multidisciplinary approach to diagnosis and management of these tumours as multiple specialities are crucial for effective treatment.
Staging
Cancer is staged using the TNM (tumour, lymph node, metastasis), where 'T' describes the extent of the primary tumour, 'N' refers to the absence/presence of lymph node involvement and 'M' refers to absence/presence of distance metastatic involvement.6 Traditionally, primary tumour staging is dependent on tumour size, extent and presence of bone invasion. The latest version of the TNM classification is shown in (Table 1) and includes depth of invasion (DOI) of the primary tumour and the presence/absence of extranodal extension (ENE).7 Depth of invasion of tongue tumours is significantly associated with increased risk of neck nodal disease and ENE is associated with poor local control and a poor prognosis.8 A joint statement on the use of the latest TNM staging has been issued recently. This supports the latest TNM staging for the description of the anatomical extent of disease in head and neck cancer.9 Survival rate is related to the stage of the disease (Table 2), so information from imaging is crucial in providing an indication of prognosis. For instance, the one-year and three-year survival rates for patients with early disease (stage one and two) is around 90% and 65% respectively but for late disease (stage three and four) drops to 80% and 45% respectively.10 Imaging is also vital so that appropriate treatment can be planned. Treatment is aimed at clearing disease and preserving oral function and quality of life. Surgery is the treatment of choice for early stage cancer11 and brachytherapy (placement of radioactive implants into the cancer) is also an option. Late stage cancer management includes surgery and reconstruction, radiotherapy and chemotherapy.3
Imaging
Imaging is primarily used in staging the disease. The Royal College of Radiologists UK recommend the following imaging modalities in the staging of oral cancer:12
-
Magnetic resonance imaging (MRI)
-
Computed tomography (CT)
-
Positron emission tomography-computed tomography (PET-CT)
-
Ultrasound.
Dental amalgam artefacts can degrade images of the oral cavity on CT and MRI (Fig. 1b) and obscure necessary detail for primary tumour staging. Following biopsy, a small lesion may be removed completely, a lesion may appear substantially smaller on imaging or conversely appear larger with added post-biopsy oedematous changes.
Magnetic resonance imaging
MRI does not use ionising radiation. The patient lies on a table inside the machine and is placed in a strong magnetic field. This causes the free protons within the patient's tissues to align with the magnetic field. A series of radio frequency pulses are then sent into the patient which alter the magnetic field of the protons. When pulses are switched off, the protons start to align with the magnet again. As they do so a signal is produced, from which a picture can be reconstructed. The type of image produced is dependent upon the sequence of the pulses sent into the patient. Paramagnetic contrast agents based on gadolinium are used with some sequences to improve the contrast of the images.
Typical sequences include:
T1 weighted: with and without contrast to show the primary tumour (Figs 2a and 2b). Post contrast images require fat suppression for better depiction of the disease within the oral cavity and neck. Tumours generally enhance with the use of contrast, making identification of the extent of the tumour easier (Fig. 2b). Pathological nodes can also be identified.
T2 weighted: demonstrates disease as a high (bright) signal. As a consequence, a T2 weighted scan may be used to visualise the primary tumour and pathological lymph nodes.
Short tau inversion recovery (STIR): this sequence suppresses the signal from fat and also shows disease as a high (bright) signal against a dark fat background (Fig. 2c). This used to identify the extent of the primary tumour in the assessment of pathological lymph nodes.
MRI has better soft-tissue resolution than CT. MRI is also better than CT at demonstrating bone marrow involvement and perineural spread and is regarded as the preferred imaging modality for staging oral cancer.13 In many cases though, CT and MRI investigations are complementary (Figs 3a, 3b and 3c). Serial MRI with post-treatment baseline scans is also used in many centres to detect recurrent disease, especially in the deeper neck regions which are not easily examined clinically (Fig. 4a). There are various benefits for each of these modalities depending on the specific circumstances (Table 3). A further development is diffusion-weighted imaging (DWI) which is an MRI technique that may have value in predicting the likely response to chemoradiation treatment and in the detection of tumour recurrence following treatment.14,15
Computed tomography
CT is a scan that involves the use of ionising radiation. The patient lies on a table and is moved through the gantry aperture of the CT machine while the x-ray source and detectors rotate around the patient. This produces a helical dataset from which axial, coronal and sagittal images can be reconstructed. Iodinated contrast is generally injected just before the scan to increase the diagnostic yield. The data from a single scan can be used to reconstruct images on both soft tissue and bony windows.
In general, MRI has superseded CT for primary tumour and nodal staging. Subject to scanner availability and radiologist preference, there are centres in the UK which use CT routinely, though the soft tissue resolution is better with MRI.
However, there is still a definite role for CT in staging. Once malignancy has been confirmed, CT body staging is recommended to assess for distant metastases. The specific protocol will vary from centre to centre. Many centres limit the CT staging to the thorax to assess for lung metastases.
There may also be a role for CT within the head and neck in addition to MRI. CT is particularly good at demonstrating cortical bone invasion (Fig. 3c). Therefore, in oral cavity malignancy, subtle encroachment into the mandibular or maxillary cortex may be assessed with high resolution CT. In a practical approach, a non-contrast CT of the maxilla or mandible can be performed at the same time as the staging CT thorax or CT body.
Cone beam CT has been suggested in the detection of mandibular invasion as it is slightly more sensitive than conventional CT, but further studies need to be undertaken before it can be recommended routinely.16
Positron emission tomography-computed tomography
For this investigation a radioisotope such as 18F-fluorodeoxyglucose (18FDG) is injected into the blood stream. The 18FGD is a glucose analogue and gets taken up preferentially by cancer cells. The 18FGD decays producing positrons which are detected by a gamma camera. The areas of increased activity are co-registered with the CT scan so the cancerous tissues may be identified. This examination carries with it a much higher radiation dose than CT and therefore its use needs to be particularly justified. Interpretation may be difficult as 18FGD is also be taken up by normal tissues such as the intrinsic tongue muscles and in inflammatory conditions such as dental abscesses.
PET-CT is mainly indicated for detecting and staging recurrent or post-treatment disease (Fig. 4b). For primary disease, PET-CT is recommended in patients with advanced stage oral cavity cancer as there is a higher risk of metastatic and distant spread. Generally, PET-CT is also recommended in those patients who present with a metastatic lymph node, with an unknown primary tumour.
Ultrasound
Ultrasound is an excellent imaging modality used in the assessment of the cervical lymph nodes. The ultrasound probe contains a transducer which sends ultrasound waves into the neck tissues. Any sound waves that are 'reflected back' are picked up by the same transducer and used to create an image on the screen. A coupling gel is placed between the probe and the skin surface to ensure a good contact. This is required so the sound waves will propagate into the tissues.
The operator moves the probe over the neck in a systematic fashion examining the lymph nodes for any signs of malignancy. Enlarged, rounded, hypoechoic (dark) nodes lacking a hilum (Fig. 5a) with a chaotic blood flow (on colour Doppler) are highly suspicious for malignancy. Needle sampling of any suspicious nodes can also be carried out under ultrasound guidance.
High resolution intraoral ultrasound with a small 'hockey-stick probe' can be used to assess tumours where accessible in the oral cavity (Fig. 5b). It can be used to depict tumour size and depth of invasion17 and is particularly helpful with small tumours which are not particularly well depicted on MRI or CT. As the new TNM classification includes depth of invasion of the tumour, ultrasound may have an increasing role in the staging of the primary tumour, particularly T1 and T2 disease.
Other radiological investigations
Panoramic radiography will show gross bony involvement by a malignant tumour (Fig. 6) and may be useful in planning resection and reconstruction planning.12 The panoramic radiograph is often requested to make a dental assessment before radiotherapy. Periapical radiographs are more accurate in detecting caries and periapical disease than panoramic radiographs so these should be used whenever possible. It is important that the appropriate dental treatment is performed before radiotherapy to help prevent osteoradionecrosis.
The doses from various investigations used in the management of oral cancer are shown in Table 4.
Multidisciplinary approach and pathways
Due to the anatomical location, oral cavity malignancy is one of the few cancers that may present to a general dental practitioner as well as the general medical practitioner. Referrals of oral cavity lesions from dentists or general practitioners suspicious of malignancy will then be fast tracked via local guidelines to an oral and maxillofacial unit. From here, they will undergo a series of investigations including the aforementioned radiological investigations. Histopathology is key and obtaining this will vary on a case by case basis. Examples include:
-
Incisional biopsy of the primary lesion under local anaesthetic in the clinic
-
Incisional biopsy of the primary lesion under general anaesthetic if the lesion is difficult to access
-
Fine needle aspiration or core biopsy of a palpable suspicious (metastatic) lymph node in the clinic setting
-
Fine needle aspiration or core biopsy of a radiologically suspicious impalpable node referred to radiology performed under ultrasound guidance.
Once the radiological and histopathological reports are available, the patient will then be discussed in the multidisciplinary meeting (MDM). This will call on the joint expertise of oral maxillofacial surgeons, oncologists, histopathologists and radiologists among other medical specialities. In particular, ear nose and throat (ENT) head & neck surgeons will naturally be a part of the head & neck oncology MDM and will offer their expertise particularly with reference to malignant encroachment into adjacent subsites such as maxillary sinuses or pharynx. While oral maxillofacial surgeons in general are adept at neck dissection for nodal disease, an ENT opinion is valuable or even a joint surgical case may be performed depending on local expertise.
There are multiple other disciplines as part of the MDM. These include specialist nurses, speech language therapists, dieticians and possibly restorative dentists dependant on local practice.
Summary
Earlier diagnosis of oral cavity malignancies, as with other subsite malignancies, will help with prognosis. Diagnosis and management of oral cavity malignancy benefits greatly from a multimodality and multidisciplinary approach.
References
Cancer Research UK. Head and neck cancers statistics. Available at https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/head-and-neck-cancers (accessed October 2018).
La'Porte S J, Juttla J K, Lingam R K . Imaging the Floor of the Mouth and the Sublingual Space. Radiographics 2011; 31: 1215–1230.
Kerawala C, Roques T, Jeannon J P, Bisase B . Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130 (S2): S83–S89.
Lingen M W, Xiao W, Schmitt A et al. Low etiologic fraction for high-risk humanpapillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2013; 49: 1–8.
Brocklehurst P R ; Baker S R ; Speight P M . Primary care clinicians and the detection and referral of potentially malignant disorders in the mouth: a summary of the current evidence. Prim Dent Care 2010; 17: 65–71.
Huang S H, O'Sullivan B . Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol 2017; 18: 40.
American Joint Committee on Cancer. Cancer staging manual. 8th ed. 2018.
Myers J N, Greenberg J S, Mo V, Roberts D . Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 2001; 92: 3030–3036.
British Association of Head and Neck Oncologists. Director of Education Committee and Director of International Collaboration Committee sought. Available at http://www.bahno.org.uk/news-information/ (accessed September 2018).
National Cancer Intelligence Network (now part of Public Health England). Oral Cavity Cancer: recent survival trends. Available at http://www.ncin.org.uk/publications/data_briefings/oral_cavity_cancer_recent_survival_trends (accessed October 2018).
NICE. Head and neck cancer. Quality standard [QS146]. 2017. Available at https://www.nice.org.uk/guidance/qs146 (accessed October 2018).
The Royal College of Radiologists. Recommendations for cross-sectional imaging in cancer management. Second edition. 2014.
Lewis-Jones H, Colley S, Gibson D . Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130 (S2): S28–S31.
Connolly M ; Srinivasan A . Diffusion-Weighted Imaging in Head and Neck Cancer: Technique, Limitations, and Applications. Magn Reson Imaging Clin N Am 2018; 26: 121–133.
Jansen J F A, Parra C, Lu Y, Shukla-Dave A . Evaluation of Head and Neck Tumours with Functional MR Imaging. Magn Reson Imaging Clin N Am 2016; 24: 123–133.
Czerwonka L, Bissada E, Goldstein D P et al. High-resolution cone-beam computed tomography for assessment of bone invasion in oral cancer: Comparison with conventional computed tomography. Head Neck 2017; 39: 2016–2020.
Yesuratnam A, Wiesenfield A, Tsui T et al. Preoperative evaluation of oral tongue squamous cell carcinomawith intraoral ultrasound and magnetic resonance imaging – comparison with histopathological tumour thickness and accuracy in guiding patient management. Int J Oral Maxillofac Surg 2014; 43: 787–794.
Brierley J D, Gospodarowicz M K, Wittekind C (eds). TNM classification of malignant tumours. 8th ed. Oxford, UK; Hoboken, NJ: John Wiley & Sons, Inc., 2017.
Vilar-Palop J, Vilar J, Hernández-Aguado I, González-Álvarez I, Lumbreras B . Updated effective doses in radiology. J Radiol Prot 2016; 36: 975–990.
Etard C, Celier D, Roch P, Aubert B . National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011. Radiat Prot Dosimetry 2012; 152: 334–338.
Horner K, Eaton K A . Selection criteria for dental radiography. Third edition. Faculty of General Dental Practice (UK), updated 2018.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Drage, N., Qureshi, S. & Lingam, R. Imaging patients with cancer of the oral cavity. Br Dent J 225, 827–832 (2018). https://doi.org/10.1038/sj.bdj.2018.929
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.2018.929